placeholder image

K. C. Demel All authors

About

Publications While At HealthPartners

selected publications

Abstract
  • CT066 / 16 - Phase 1 study of MDM2 antagonist ASTX295 in patients with solid tumors with wild-type TP53 [abstract]
    2024
  • Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with Pembrolizumab: clinical update [abstract]. 
    Journal of Clinical Oncology. 2024

    • presentations

    Contact

    full name

  • K. C. Demel

    • Quick Info

    Publications

    Collaboration